ADI vs CLDX · P/E 61, rev $11.02B vs rev $37.0K
Analog Devices Inc (ADI) versus Celldex Therapeutics Inc (CLDX) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. CLDX currently screens at market cap $2.35B.
Not investment advice. Open the ADI and CLDX stock pages for the full models.
Not investment advice.